Asymchem Laboratories (Tianjin) Co., Ltd. (SHE:002821)
China · Delayed Price · Currency is CNY 123.58
-4.50 (-3.51%)
May 8, 2026, 3:04 PM CST
SHE:002821 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,110 | 1,133 | 948.95 | 2,269 | 3,302 | 1,069 |
Depreciation & Amortization | 547.39 | 547.39 | 502.51 | 463.94 | 354.26 | 212.86 |
Other Amortization | 27.4 | 27.4 | 23.62 | 22.92 | 7.71 | 3.88 |
Loss (Gain) From Sale of Assets | 2.57 | 2.57 | -0.07 | 0.01 | 5.53 | 0.93 |
Asset Writedown & Restructuring Costs | 9.04 | 9.04 | 23.97 | 19.27 | - | - |
Loss (Gain) From Sale of Investments | -111.02 | -111.02 | -122.13 | -154.9 | -77.51 | -18.97 |
Loss (Gain) on Equity Investments | - | - | - | - | -33.05 | 3.84 |
Stock-Based Compensation | - | - | - | - | 52.87 | 51.06 |
Provision & Write-off of Bad Debts | 70.45 | 70.45 | 5.42 | 5.67 | 25.79 | 22.38 |
Other Operating Activities | 173.31 | 73.7 | -184.19 | -61.25 | -235.12 | -33.07 |
Change in Accounts Receivable | -265.55 | -265.55 | 105.23 | 500.83 | -721.26 | -853.01 |
Change in Inventory | -335.75 | -335.75 | -295.06 | 554.25 | -114.3 | -669.73 |
Change in Accounts Payable | 340.92 | 340.92 | 268.89 | -99.01 | 18.12 | 173.25 |
Change in Other Net Operating Assets | -33.77 | -33.77 | -5.06 | 36.44 | 702.23 | 150.45 |
Operating Cash Flow | 1,485 | 1,408 | 1,254 | 3,550 | 3,287 | 113.15 |
Operating Cash Flow Growth | 22.41% | 12.22% | -64.66% | 8.00% | 2804.91% | -80.25% |
Capital Expenditures | -1,376 | -1,270 | -1,130 | -1,242 | -2,151 | -1,660 |
Sale of Property, Plant & Equipment | 0.27 | 0.04 | 0.51 | 38.92 | 0.01 | 0.01 |
Cash Acquisitions | - | - | -246.9 | -11.51 | -30 | -102.53 |
Divestitures | - | - | 3.68 | 71.46 | - | - |
Investment in Securities | -289.93 | 430.39 | 39.56 | -1,751 | -2,567 | -458.99 |
Other Investing Activities | 241.59 | 206.73 | 148.82 | 202.75 | 76.59 | 16.04 |
Investing Cash Flow | -1,424 | -633.2 | -1,184 | -2,691 | -4,671 | -2,205 |
Short-Term Debt Issued | - | - | - | 12.23 | - | 1,057 |
Total Debt Issued | - | - | - | 12.23 | - | 1,057 |
Short-Term Debt Repaid | - | - | - | - | -374.57 | -692.69 |
Long-Term Debt Repaid | - | -62.85 | -47.84 | -35.48 | -14.84 | -8.1 |
Total Debt Repaid | -62.85 | -62.85 | -47.84 | -35.48 | -389.41 | -700.78 |
Net Debt Issued (Repaid) | -62.85 | -62.85 | -47.84 | -23.25 | -389.41 | 356.29 |
Issuance of Common Stock | 175.85 | 175.85 | - | 155.04 | 370.96 | 6,015 |
Repurchase of Common Stock | -62.59 | -62.59 | -1,013 | -9.32 | -814.58 | -6.57 |
Common Dividends Paid | -395.07 | -395.07 | -641.94 | -664.51 | -211.27 | -145.56 |
Other Financing Activities | 0.79 | -0.17 | -225.01 | - | 301.78 | -8.1 |
Financing Cash Flow | -343.87 | -344.83 | -1,928 | -542.03 | -742.53 | 6,211 |
Foreign Exchange Rate Adjustments | -143.18 | -35.43 | 95.78 | 36.96 | 313.18 | -8.18 |
Net Cash Flow | -426.26 | 394.12 | -1,762 | 353.43 | -1,814 | 4,110 |
Free Cash Flow | 108.86 | 137.22 | 124.33 | 2,308 | 1,136 | -1,547 |
Free Cash Flow Growth | -32.18% | 10.37% | -94.61% | 103.13% | - | - |
Free Cash Flow Margin | 1.57% | 2.06% | 2.14% | 29.50% | 11.11% | -33.39% |
Free Cash Flow Per Share | 0.30 | 0.38 | 0.35 | 6.37 | 3.10 | -4.53 |
Cash Interest Paid | - | - | - | - | 11.5 | 8.1 |
Cash Income Tax Paid | 22.64 | -12.93 | 38.36 | 228.9 | 671.7 | 120.08 |
Levered Free Cash Flow | -180.19 | -167.25 | -431.19 | 1,378 | -211.25 | -1,611 |
Unlevered Free Cash Flow | -172.16 | -159.28 | -425.25 | 1,382 | -204.67 | -1,607 |
Change in Working Capital | -344.51 | -344.51 | 56.27 | 985.25 | -115.2 | -1,199 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.